Sarepta Therapeutics Inc (NASDAQ: SRPT) is -5.05% lower on its value in year-to-date trading and has touched a low of $102.15 and a high of $173.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SRPT stock was last observed hovering at around $117.51 in the last trading session, with the day’s loss setting it -2.06%.
Currently trading at $115.45, the stock is -4.05% and -4.53% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.9 million and changing -1.75% at the moment leaves the stock -10.54% off its SMA200. SRPT registered -2.76% loss for a year compared to 6-month loss of -20.94%. The firm has a 50-day simple moving average (SMA 50) of $120.9284 and a 200-day simple moving average (SMA200) of $129.0477.
The stock witnessed a -6.42% gain in the last 1 month and extending the period to 3 months gives it a -11.96%, and is -0.55% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.12% over the week and 3.56% over the month.
Sarepta Therapeutics Inc (SRPT) has around 1314 employees, a market worth around $11.03B and $1.64B in sales. Current P/E ratio is 95.90 and Fwd P/E is 9.84. Profit margin for the company is 7.43%. Distance from 52-week low is 13.01% and -33.36% from its 52-week high. The company has generated returns on investments over the last 12 months (4.82%).
with sales reaching $629.3M over the same period.The EPS is expected to grow by 144.76% this year, but quarterly earnings will post 47.88% year-over-year. Quarterly sales are estimated to grow 58.60% in year-over-year returns.
652.0 institutions hold shares in Sarepta Therapeutics Inc (SRPT), with institutional investors hold 96.55% of the company’s shares. The shares outstanding are 95.49M, and float is at 89.56M with Short Float at 5.56%. Institutions hold 92.32% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 10.32 million shares valued at $1.63 billion. The investor’s holdings represent 10.9845 of the SRPT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 9.04 million shares valued at $1.43 billion to account for 9.6133 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.32 million shares representing 4.5971 and valued at over $682.69 million, while STATE STREET CORP holds 4.4066 of the shares totaling 4.14 million with a market value of $654.4 million.
Sarepta Therapeutics Inc (SRPT) Insider Activity
The most recent transaction is an insider sale by Wigzell Hans Lennart Rudolf, the company’s Director. SEC filings show that Wigzell Hans Lennart Rudolf sold 10,500 shares of the company’s common stock on Dec 12 ’24 at a price of $124.84 per share for a total of $1.31 million. Following the sale, the insider now owns 22840.0 shares.
Still, SEC filings show that on Dec 05 ’24, Boor Kathryn Jean (Director) disposed off 1,636 shares at an average price of $125.55 for $0.21 million. The insider now directly holds 5,880 shares of Sarepta Therapeutics Inc (SRPT).
